KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Other Non-Current Liabilities: 2015-2025

Historic Other Non-Current Liabilities for Medpace Holdings (MEDP) over the last 9 years, with Sep 2025 value amounting to $54.5 million.

  • Medpace Holdings' Other Non-Current Liabilities rose 77.48% to $54.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.5 million, marking a year-over-year increase of 77.48%. This contributed to the annual value of $42.7 million for FY2024, which is 51.43% up from last year.
  • Per Medpace Holdings' latest filing, its Other Non-Current Liabilities stood at $54.5 million for Q3 2025, which was up 4.96% from $51.9 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Other Non-Current Liabilities ranged from a high of $54.5 million in Q3 2025 and a low of $16.1 million during Q3 2021.
  • Its 3-year average for Other Non-Current Liabilities is $35.3 million, with a median of $29.3 million in 2024.
  • Data for Medpace Holdings' Other Non-Current Liabilities shows a peak YoY skyrocketed of 82.07% (in 2025) over the last 5 years.
  • Over the past 5 years, Medpace Holdings' Other Non-Current Liabilities (Quarterly) stood at $17.7 million in 2021, then rose by 27.93% to $22.7 million in 2022, then increased by 24.32% to $28.2 million in 2023, then skyrocketed by 51.43% to $42.7 million in 2024, then spiked by 77.48% to $54.5 million in 2025.
  • Its last three reported values are $54.5 million in Q3 2025, $51.9 million for Q2 2025, and $53.0 million during Q1 2025.